Cargando…
αvβ3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model
Pancreatic cancer decreases survival time and quality of life because of drug resistance and peripheral neuropathy during conventional treatment. This study was undertaken to investigate whether αvβ3 integrin receptor antagonist compounds NDAT and XT199 can suppress the development of cisplatin resi...
Autores principales: | Debreli Coskun, Melis, Sudha, Thangirala, Bharali, Dhruba J., Celikler, Serap, Davis, Paul J., Mousa, Shaker A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056702/ https://www.ncbi.nlm.nih.gov/pubmed/32174830 http://dx.doi.org/10.3389/fphar.2020.00095 |
Ejemplares similares
-
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac
por: Sudha, Thangirala, et al.
Publicado: (2017) -
Nano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degeneration
por: Jayaraman, Melamangalam S., et al.
Publicado: (2012) -
Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts
por: Sudha, Thangirala, et al.
Publicado: (2017) -
Editorial Expression of Concern: Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles
por: Yalcin, Murat, et al.
Publicado: (2023) -
Resveratrol and Its Nanoformulation Attenuate Growth and the Angiogenesis of Xenograft and Orthotopic Colon Cancer Models
por: Sudha, Thangirala, et al.
Publicado: (2020)